Patent · US Expired

Selective cyclic peptides with melanocortin-4 receptor (MC4-R) agonist activity

US7045591B2 · kind B2 · utility

4Cited by
2References
76Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2001
Grant dateMay 16, 2006
Priority date—
Expiry dateSep 13, 2023

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptides cyclized via disulfide or lactam bridges are disclosed. The peptides exhibit melanocortin-4 receptor agonist activity and are useful for treating obesity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.